Loading financial data...

Addex Therapeutics Ltd. (ADXN) SEC Filings | Global Financial Data

Addex Therapeutics Ltd.

ADXNSEC EDGAR

Pharmaceutical Preparations(V8)CIK: 1574232

6-K

FORM 6-K

Filed: Feb 3, 2026 | Report: Feb 3, 2026

View on SEC

6-K

FORM 6-K

Filed: Jan 7, 2026 | Report: Jan 7, 2026

View on SEC

6-K

FORM 6-K

Filed: Dec 10, 2025 | Report: Dec 10, 2025

Filed: Dec 4, 2025 | Report: Dec 4, 2025

Filed: Oct 29, 2025 | Report: Oct 29, 2025

View on SEC

6-K

FORM 6-K

Filed: Sep 30, 2025 | Report: Jun 30, 2025

View on SEC

6-K

FORM 6-K

Filed: Sep 23, 2025 | Report: Sep 23, 2025

View on SEC

6-K

FORM 6-K

Filed: Jun 30, 2025 | Report: Jun 30, 2025

View on SEC

6-K

FORM 6-K

Filed: Jun 25, 2025 | Report: Jun 25, 2025

Filed: Jun 20, 2025 | Report: Jun 20, 2025

View on SEC

6-K

FORM 6-K

Filed: Jun 6, 2025 | Report: Jun 6, 2025

View on SEC

20-F

FORM 20-F

Filed: May 15, 2025 | Report: Dec 31, 2024

View on SEC

6-K

FORM 6-K

Filed: May 12, 2025 | Report: May 12, 2025

View on SEC

NT 20-F

Filed: Apr 30, 2025 | Report: Dec 31, 2024

View on SEC

6-K

FORM 6-K

Filed: Apr 30, 2025 | Report: Apr 30, 2025

View on SEC

6-K

FORM 6-K

Filed: Apr 25, 2025 | Report: Apr 25, 2025

View on SEC

6-K

FORM 6-K

Filed: Apr 17, 2025 | Report: Apr 17, 2025

View on SEC

6-K

FORM 6-K

Filed: Nov 22, 2024 | Report: Nov 22, 2024

View on SEC

6-K

FORM 6-K

Filed: Nov 12, 2024 | Report: Nov 11, 2024

View on SEC

6-K

FORM 6-K

Filed: Sep 30, 2024 | Report: Sep 30, 2024

View on SEC

6-K

FORM 6-K

Filed: Sep 19, 2024 | Report: Sep 19, 2024

View on SEC

6-K

FORM 6-K

Filed: Aug 27, 2024 | Report: Aug 27, 2024

View on SEC

SC 13D/A

GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#7E)

Filed: Aug 14, 2024

View on SEC

SC 13D/A

GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#6)

Filed: Jul 22, 2024 | Report: Jul 22, 2024

View on SEC

6-K

FORM 6-K

Filed: Jul 15, 2024 | Report: Jul 15, 2024

View on SEC

6-K

FORM 6-K

Filed: Jul 1, 2024 | Report: Jul 1, 2024

View on SEC

6-K

FORM 6-K

Filed: Jun 6, 2024 | Report: Jun 6, 2024

View on SEC

6-K

FORM 6-K

Filed: Jun 5, 2024 | Report: Jun 5, 2024

View on SEC

6-K

FORM 6-K

Filed: Apr 29, 2024 | Report: Apr 29, 2024

Filed: Apr 18, 2024 | Report: Dec 31, 2023

View on SEC

6-K

FORM 6-K

Filed: Apr 18, 2024 | Report: Apr 18, 2024

View on SEC

6-K

FORM 6-K

Filed: Apr 3, 2024 | Report: Apr 3, 2024

Filed: Jan 30, 2024 | Report: Jan 30, 2024

View on SEC

6-K/A

FORM 6-K/A

Filed: Dec 21, 2023 | Report: Jun 30, 2023

View on SEC

6-K

FORM 6-K

Filed: Dec 20, 2023 | Report: Dec 20, 2023

View on SEC

6-K

FORM 6-K

Filed: Dec 14, 2023 | Report: Dec 14, 2023

View on SEC

SC 13D/A

GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A(#5)

Build with this data

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)

Get API Key (Free)